Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 86 (1), 76-83

A Comprehensive Model for Familial Breast Cancer Incorporating BRCA1, BRCA2 and Other Genes


A Comprehensive Model for Familial Breast Cancer Incorporating BRCA1, BRCA2 and Other Genes

A C Antoniou et al. Br J Cancer.


In computing the probability that a woman is a BRCA1 or BRCA2 carrier for genetic counselling purposes, it is important to allow for the fact that other breast cancer susceptibility genes may exist. We used data from both a population based series of breast cancer cases and high risk families in the UK, with information on BRCA1 and BRCA2 mutation status, to investigate the genetic models that can best explain familial breast cancer outside BRCA1 and BRCA2 families. We also evaluated the evidence for risk modifiers in BRCA1 and BRCA2 carriers. We estimated the simultaneous effects of BRCA1, BRCA2, a third hypothetical gene 'BRCA3', and a polygenic effect using segregation analysis. The hypergeometric polygenic model was used to approximate polygenic inheritance and the effect of risk modifiers. BRCA1 and BRCA2 could not explain all the observed familial clustering. The best fitting model for the residual familial breast cancer was the polygenic, although a model with a single recessive allele produced a similar fit. There was also significant evidence for a modifying effect of other genes on the risks of breast cancer in BRCA1 and BRCA2 mutation carriers. Under this model, the frequency of BRCA1 was estimated to be 0.051% (95% CI: 0.021-0.125%) and of BRCA2 0.068% (95% CI: 0.033-0.141%). The breast cancer risk by age 70 years, based on the average incidence over all modifiers was estimated to be 35.3% for BRCA1 and 50.3% for BRCA2. The corresponding ovarian cancer risks were 25.9% for BRCA1 and 9.1% for BRCA2. The findings suggest that several common, low penetrance genes with multiplicative effects on risk may account for the residual non-BRCA1/2 familial aggregation of breast cancer. The modifying effect may explain the previously reported differences between population based estimates for BRCA1/2 penetrance and estimates based on high-risk families.

Similar articles

See all similar articles

Cited by 96 PubMed Central articles

See all "Cited by" articles


    1. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716–726.
    1. Antoniou AC, Gayther SA, Stratton JF, Ponder BAJ, Easton DF. Risk models for familial ovarian and breast cancer. Genet Epidemiol. 2000;18:173–190. - PubMed
    1. Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton DF. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet Epidemiol. 2001;21:1–18. - PubMed
    1. Claus EB, Risch N, Thompson D. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet. 1991;48:232–242. - PMC - PubMed
    1. Cox DR, Oakes D. London: Chapman and Hall; 1984. Analysis of survival data.

Publication types